Interim 18F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine-Reference-Cited by-同舟云学术

Interim 18F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine

Published:2017-07-19 Issue:9 Volume:96 Page:1509-1515
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Jo Jae-Cheol,Yoon Dok Hyun,Kim Shin,Lee Kyoungmin,Kang Eun Hee,Park Jung Sun,Ryu Jin-Sook,Huh Jooryung,Park Chan-Sik,Kim Jong Hoon,Lee Sang Wook,Suh Cheolwon

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-017-3068-9/fulltext.html

Reference23 articles.

1. Rubenstein J, Ferreri AJ, Pittaluga S (2008) Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment. Leukemia & lymphoma 49(Suppl 1):43–51. doi: 10.1080/10428190802311441

2. Huh J (2012) Epidemiologic overview of malignant lymphoma. Korean J Hematol 47(2):92–104

3. Ferreri AJ, Blay JY, Reni M, Pasini F, Spina M, Ambrosetti A, Calderoni A, Rossi A, Vavassori V, Conconi A, Devizzi L, Berger F, Ponzoni M, Borisch B, Tinguely M, Cerati M, Milani M, Orvieto E, Sanchez J, Chevreau C, Dell'Oro S, Zucca E, Cavalli F (2003) Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 21(2):266–272

4. Abrey LE, Ben-Porat L, Panageas KS, Yahalom J, Berkey B, Curran W, Schultz C, Leibel S, Nelson D, Mehta M, DeAngelis LM (2006) Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 24(36):5711–5715. doi: 10.1200/jco.2006.08.2941

5. Terasawa T, Lau J, Bardet S, Couturier O, Hotta T, Hutchings M, Nihashi T, Nagai H (2009) Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(11):1906–1914. doi: 10.1200/jco.2008.16.0861

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the intracranial metabolic score as a novel prognostic tool in immunocompetent primary CNS lymphoma patients with end-of-treatment 18F-FDG PET/CT and PET/MR;2024-07-16

2. Interim FDG-PET improves treatment failure prediction in primary central nervous system lymphoma: An LOC network prospective multicentric study;Neuro-Oncology;2024-02-16

3. Comparative evaluation of 11C-methionine and 18F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma;Journal of Neuro-Oncology;2023-12-31

4. Clinical Value of PET.CT Based on Big Data in Colorectal and Peritoneal Metastatic Cancer;Contrast Media & Molecular Imaging;2022-09-30

5. Role of Positron Emission Tomography in Primary Central Nervous System Lymphoma;Cancers;2022-08-23